Remote Delivery of a Mindfulness-based Intervention for Tics
Launched by JOHNS HOPKINS UNIVERSITY · May 6, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new approach to help people with Tourette Syndrome and other tic disorders by comparing two types of therapy. One is a mindfulness-based intervention aimed at reducing tics, while the other is a more traditional method that includes relaxation techniques and supportive therapy. The goal of the study is to find out which method might be more effective in improving the lives of those with Tourette Syndrome.
To participate in this study, individuals need to be at least 18 years old, have a confirmed diagnosis of Tourette Syndrome or a tic disorder, and have moderate to severe tics. Participants should not be on any medications for at least eight weeks before joining and should not be receiving therapy for other conditions. If eligible, participants can expect to engage in remote sessions using their smartphone or tablet, allowing for flexibility and convenience. This research could lead to better treatment options for individuals dealing with tics, making a positive difference in their daily lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. be ≥18 years of age;
- • 2. meet diagnostic criteria for a primary or co-primary diagnosis of Tourette Syndrome or a Persistent Motor or Vocal Tic Disorder on a structured clinical interview;
- • 3. have moderate or greater tic severity as evidenced by a YGTSS Total Tic Score of \>14 (when motor and vocal tics are present) or \>10 (when only motor or vocal tics are present);
- • 4. be medication free and/or on a stable dose of psychiatric medication 8 weeks prior to study participation;
- • 5. be not engaged in psychotherapy for non-TS conditions and/or be on a stable course of therapy for 6 months prior to study participation
- • 6. be fluent in English;
- • 7. have access to a smart phone and/or tablet.
- Exclusion Criteria:
- • 1. a current diagnosis of substance use disorder, psychosis, mania or another condition that requires another form of care;
- • 2. severe current suicidal/homicidal ideation and/or self-injury requiring medical intervention;
- • 3. concurrent psychotherapy for TS;
- • 4. prior extensive experience with mindfulness and/or meditation.
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Joseph F McGuire, PhD
Principal Investigator
Johns Hopkins University
Hannah Reese, PhD
Principal Investigator
Bowdoin College
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported